- Home
- GTEC vs OSRH Comparison
GTEC vs OSRH Comparison
Compare GTEC & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GTEC | OSRH |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.9M | 18.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GTEC | OSRH |
|---|---|---|
| Price | $0.72 | $0.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 132.7K | ★ 387.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.64 | N/A |
| Revenue Next Year | $3.93 | N/A |
| P/E Ratio | $1.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.58 | $0.38 |
| 52 Week High | $2.58 | $4.33 |
Technical Indicators
Market Signals| Indicator | GTEC | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 42.01 | 46.42 |
| Support Level | $0.66 | $0.39 |
| Resistance Level | $1.16 | $0.74 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 37.32 | 43.08 |
Price Performance
Historical ComparisonAbout GTEC Greenland Technologies Holding Corporation
Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.